While mutations affecting genes coding for NF-κB proteins are relatively rare in DLBCL, erroneous NF-κB activation is often observed due to other oncogenic events affecting the upstream signaling network. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.